Cargando…

Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children

Detalles Bibliográficos
Autores principales:	Conte, Edoardo, Leoni, Olivia, Ammirati, Enrico, Imazio, Massimo, Brucato, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250150/ https://www.ncbi.nlm.nih.gov/pubmed/37311686 http://dx.doi.org/10.1016/j.ejim.2023.06.002

Ejemplares similares

Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis
por: Ammirati, Enrico, et al.
Publicado: (2022)

Recurrent pericarditis: an update on diagnosis and management
por: Andreis, Alessandro, et al.
Publicado: (2021)

Anti-interleukin-1 agents for pericarditis: a primer for cardiologists( )
por: Imazio, Massimo, et al.
Publicado: (2021)

Targeting inflammatory citokines to prevent constriction in tuberculous pericarditis and beyond?
por: Imazio, Massimo
Publicado: (2018)

Recurrent Pericarditis in Children and Adolescents
por: Tombetti, Enrico, et al.
Publicado: (2019)

COVID-19, Myocarditis and Pericarditis
por: Fairweather, DeLisa, et al.
Publicado: (2023)

CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis
por: Markel, Gal, et al.
Publicado: (2016)

The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study
por: Tuvali, Ortal, et al.
Publicado: (2022)

Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis
por: Brucato, Antonio, et al.
Publicado: (2023)

Myocarditis and Pericarditis in Patients with COVID-19
por: Shah, Jassim Zaheen, et al.
Publicado: (2020)

Tozinameran: Myocarditis and pericarditis: case report
Publicado: (2022)

Value of cardiovascular magnetic resonance in patients with suspected inflammatory pericarditis
por: Cruz, Inês, et al.
Publicado: (2015)

Myocarditis and pericarditis after vaccination for COVID‐19
por: Hudson, Blake, et al.
Publicado: (2021)

Myocarditis, pericarditis with COVID-19 vaccines in the Netherlands
Publicado: (2021)

Myocarditis or pericarditis following COVID-19 vaccination
Publicado: (2021)

Myocarditis and pericarditis after COVID-19 vaccination
Publicado: (2021)

Emerging Therapies for Recurrent Pericarditis: Interleukin‐1 inhibitors
por: Lo Presti, Saberio, et al.
Publicado: (2021)

Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy
por: Corrao, Giovanni, et al.
Publicado: (2022)

Natriuretic peptides to differentiate constrictive pericarditis and restrictive cardiomyopathy: A systematic review and meta‐analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2021)

Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020
por: Tombetti, Enrico, et al.
Publicado: (2020)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
por: Pepe, Salvatore, et al.
Publicado: (2021)

Myocarditis, pericarditis included in labelling for two COVID vaccines
Publicado: (2021)

COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
por: Mahasing, Chayanit, et al.
Publicado: (2023)

Recovery from mRNA COVID-19 vaccine-related myocarditis
por: Ammirati, Enrico, et al.
Publicado: (2022)

New concepts in fulminant myocarditis and risk of cardiac mortality
por: Ammirati, Enrico, et al.
Publicado: (2017)

The Role of Endocarditis, Myocarditis and Pericarditis in Qualitative and Quantitative Data Analysis
por: Schöffel, Norman, et al.
Publicado: (2009)

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
por: Calcaterra, Giuseppe, et al.
Publicado: (2021)

PRAC updates risk of myocarditis and pericarditis with mRNA vaccines
Publicado: (2021)

Elasomeran/tozinameran: Myocarditis, perimyocarditis and pericarditis: 16 case reports
Publicado: (2022)

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
por: Weintraub, Eric S., et al.
Publicado: (2022)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
por: Hajjo, Rima, et al.
Publicado: (2021)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
por: Alami, Abdallah, et al.
Publicado: (2023)

A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination
por: Engler, Renata J. M., et al.
Publicado: (2015)

Response to case report on myocarditis and pericarditis after COVID‐19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Constrictive pericarditis caused by viral myocarditis in children: a brief report
por: Lei, Haiyan, et al.
Publicado: (2022)

Update on acute myocarditis
por: Ammirati, Enrico, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5qsnqa2e8k53bbnvkij9jgusbs